
GenSight Biologics
Develops innovative therapies for mitochondrial and neurodegenerative diseases.
Market cap
$27.4m
Enterprise value
$41m
Share price
€0.16 SIGHT.PA
Company register number
751164757
Authorizing premium user...
Develops innovative therapies for mitochondrial and neurodegenerative diseases.